Evidence map›Paper›PMID 24395985›Full record

Trial reportJournal of the National Cancer Institute. Monographs2013

Improving symptom communication through personal digital assistants: the CHAT (Communicating Health Assisted by Technology) project.

Douglas M Post, Charles L Shapiro, Donald J Cegala, Prabu David, Mira L Katz, Jessica L Krok, Gary S Phillips, Ann Sheck McAlearney, Jennifer S Lehman, William Hicks and 1 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the National Cancer Institute. Monographs, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Hispanic breast cancer patients' symptom experience and patient-physician communication during chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Cancer prevention and control in the changing communication landscape.Journal of the National Cancer Institute. Monographs · 2013
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Douglas M Post1590 North High St, Ste 525, Columbus, OH 43201. doug.post@osumc.edu.
Charles L Shapiro
Donald J Cegala
Prabu David
Mira L Katz
Jessica L Krok
Gary S Phillips
Ann Sheck McAlearney
Jennifer S Lehman
William Hicks
Electra D Paskett
The Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
TRAINING AND CAREER DEVELOPMENTP50CA105632 · NCI · OHIO STATE UNIVERSITY · PI PASKETT, ELECTRA D. · 2003 to 2016
$17.2M
Patient-Centered Communication During ChemotherapyR21CA115388 · NCI · OHIO STATE UNIVERSITY · PI POST, DOUGLAS M · 2005 to 2006
$238k
NCI NIH HHS CA115388-02NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA105632
6 · The paper itself

Abstract

backgroundCommunication problems impede effective symptom management during chemotherapy. The primary aim of this pilot randomized controlled trial was to test the effects of a personal digital assistant-delivered communication intervention on pain, depression, and fatigue symptoms among breast cancer patients undergoing chemotherapy. Secondary aims included assessment of 1) study feasibility, 2) patient and clinician responses to study participation, and 3) intervention effects on health-related quality of life (HRQoL) and communication self-efficacy.

methodsIntervention group participants (n = 27) completed symptom inventories at baseline, once per week during treatment, and at posttreatment. Depending on symptom severity, they viewed race-concordant videos on how to communicate about pain, depression and/or fatigue, using the personal digital assistant. Symptom records were tracked and shared with clinicians. Control group participants (n = 23) received usual care. Longitudinal random effects modeling assessed the changes in average symptom scores over time. Descriptive statistics assessed study feasibility and intervention effects on HRQoL and communication self-efficacy. Postintervention focus groups, interviews, and surveys assessed responses to study participation.

resultsMean age of the participants was 51.0 years; 42 participants (84%) were white. In comparison with control, intervention group participants reported lower average pain severity over time (P = .015). Mean pain interference scores over time were marginally different between groups (P = .07); mean depression and fatigue scores over time were statistically nonsignificant. Feasibility outcomes and perspectives about study participation were positive. Mean pre-post decreases in HRQoL were generally higher among intervention group participants; pre-post changes in communication self-efficacy were equivalent.

conclusionMixed findings of the study indicate the need for future research.

Indexed as

Computers, HandheldAntineoplastic AgentsBreast NeoplasmsDepressionFatigueFemaleHealth CommunicationHumansMiddle AgedPainPain MeasurementPilot ProjectsQuality of LifeSurveys and QuestionnairesAntineoplastic Agents

Identifiers

PMID24395985
PMCPMC3881996
OpenAlexW2113561834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.